This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ho, M. Articles by Bryan, L. E. Search for Related Content PubMed PubMed Citation Articles by Ho, M. Articles by Bryan, L. E.

 Previous Article  |  Next Article 

Infect. Immun., 09 1997, 3648-3653, Vol 65, No. 9
Copyright © 1997, American Society for Microbiology

Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies

M Ho, T Schollaardt, MD Smith, MB Perry, PJ Brett, W Chaowagul and LE Bryan
Department of Microbiology and Infectious Diseases, University of Calgary, Alberta, Canada.

The lipopolysaccharide (LPS) of Burkholderia pseudomallei, the causative agent of melioidosis, consists of two O-antigenic polysaccharides designated O-PS I and O-PS II. In this study, the O-PS specificity and functional activity of a protective polyclonal antiserum and an immunoglobulin M (IgM) monoclonal antibody were determined. The polyclonal antiserum recognized both O-PS I and O-PS II, while the monoclonal antibody was O-PS II specific. Both mediated phagocytic killing of B. pseudomallei by polymorphonuclear leukocytes. Patients acutely infected with B. pseudomallei also produced antibodies to the two O-PSs, but these antibodies were not produced by asymptomatic individuals from an area of endemicity who were seropositive by an indirect hemagglutination test using sonicated heat- killed whole organisms as antigen. IgM antibodies were detected only in patients with localized infection. IgG antibodies were detected in all acutely infected patients, but there was no significant difference in antibody levels among patients with localized infection, patients who survived septicemic illness, and patients who died from septicemic illness. Further analysis of the IgG response revealed production of IgG1 and IgG2 antibodies by all patient groups, while an IgG3 response was seen only in survivors of septicemic infection. IgG4 was not detectable even when a fivefold-lower serum dilution was used. Patient sera also mediated phagocytic killing by polymorphonuclear leukocytes, and the killing effect was enhanced by complement. These results suggest that antibodies to the LPS O-polysaccharides of B. pseudomallei are protective by promoting phagocytic killing. The antibodies develop during human infection and may facilitate clearance of the organisms, as seen in a diabetic rat model of B. pseudomallei infection.

This article has been cited by other articles:

• Arjcharoen, S., Wikraiphat, C., Pudla, M., Limposuwan, K., Woods, D. E., Sirisinha, S., Utaisincharoen, P. (2007). Fate of a Burkholderia pseudomallei Lipopolysaccharide Mutant in the Mouse Macrophage Cell Line RAW 264.7: Possible Role for the O-Antigenic Polysaccharide Moiety of Lipopolysaccharide in Internalization and Intracellular Survival. Infect. Immun. 75: 4298-4304 [Abstract] [Full Text]  
• Zou, N., Newsome, T., Li, B., Tsai, S., Lo, S.-C. (2007). Human Single-Chain Fv Antibodies Against Burkholderia mallei and Burkholderia pseudomallei. Exp. Biol. Med. 232: 550-556 [Abstract] [Full Text]  
• Elvin, S. J., Healey, G. D., Westwood, A., Knight, S. C., Eyles, J. E., Williamson, E. D. (2006). Protection against Heterologous Burkholderia pseudomallei Strains by Dendritic Cell Immunization. Infect. Immun. 74: 1706-1711 [Abstract] [Full Text]  
• Cheng, A. C., Currie, B. J. (2005). Melioidosis: Epidemiology, Pathophysiology, and Management. Clin. Microbiol. Rev. 18: 383-416 [Abstract] [Full Text]  
• Nelson, M., Prior, J. L, Lever, M S., Jones, H. E, Atkins, T. P, Titball, R. W (2004). Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol 53: 1177-1182 [Abstract] [Full Text]  
• JONES, S.M., ELLIS, J.F., RUSSELL, P., GRIFFIN, K.F., OYSTON, P.C. F. (2002). Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol 51: 1055-1062 [Abstract] [Full Text]  
• CHENTHAMARAKSHAN, V., KUMUTHA, M.V., VADIVELU, J., PUTHUCHEARY, S.D. (2001). Distribution of immunoglobulin classes and IgG subclasses against a culture filtrate antigen of Burkholderia pseudomallei in melioidosis patients. J Med Microbiol 50: 55-61 [Abstract] [Full Text]  
• Burtnick, M. N., Woods, D. E. (1999). Isolation of Polymyxin B-Susceptible Mutants of Burkholderia pseudomallei and Molecular Characterization of Genetic Loci Involved in Polymyxin B Resistance. Antimicrob. Agents Chemother. 43: 2648-2656 [Abstract] [Full Text]  
• Weiss, A. A., Mobberley, P. S., Fernandez, R. C., Mink, C. M. (1999). Characterization of Human Bactericidal Antibodies to Bordetella pertussis. Infect. Immun. 67: 1424-1431 [Abstract] [Full Text]  
• Anuntagool, N., Intachote, P., Wuthiekanun, V., White, N. J., Sirisinha, S. (1998). Lipopolysaccharide from Nonvirulent Ara+ Burkholderia pseudomallei Isolates Is Immunologically Indistinguishable from Lipopolysaccharide from Virulent Ara- Clinical Isolates. CVI 5: 225-229 [Abstract] [Full Text]